Ciclosporin eye drops launched for keratitis

The recommended dose of Ikervis is one drop applied to the affected eye(s) once daily at bedtime.
The recommended dose of Ikervis is one drop applied to the affected eye(s) once daily at bedtime.

Further information
View Ikervis drug record
Summary of Product Characteristics
Manufacturer: Santen

Ikervis (ciclosporin) is indicated for the treatment of severe keratitis in adults with dry eye disease that has not improved despite treatment with tear substitutes.

As an immunosuppressant, ciclosporin acts to improve ocular surface damage and reduce inflammation.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases